Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team

Treatment options for early-stage (T1-2 N0) non-small cell lung cancer are often limited by the patient's advanced age, poor performance status, and comorbidities. Despite these challenges, stereotactic ablative radiotherapy (SABR) provides a highly effective and safe therapy for intrathoracic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirvani, Shervin M., Chang, Joe Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759204/
https://www.ncbi.nlm.nih.gov/pubmed/24212962
http://dx.doi.org/10.3390/cancers3033432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759204/
https://www.ncbi.nlm.nih.gov/pubmed/24212962
http://dx.doi.org/10.3390/cancers3033432

Ejemplares similares